Characteristics of Study Cohorts
The samples in this study were obtained from participants recruited in Egypt and the US. The Egyptian participants consist of adult patients (40 HCC cases and 49 patients with liver cirrhosis) recruited from the outpatient clinics and inpatient wards of the Tanta University Hospital, Tanta, Egypt (TU cohort). The characteristics of the patient population in the TU cohort are summarized in Table S1 . All participating patients provided informed consent before taking part in the study. The study protocol was approved by the Tanta University Ethical Committee. Patients were diagnosed to have cirrhosis on the basis of established clinical, laboratory and/or imaging criteria with ultrasound examination. Cases were suspected to have HCC if they had focal lesion in ultrasound examination and/or elevated AFP above 200 ng/ml, but only diagnosed to have HCC based on well-established diagnostic imaging criteria with spiral CT scanning and/or histopathology examination of liver biopsy. Clinical stages for HCC cases were determined based on the TNM staging system. Suspected cases that were not confirmed by CT or biopsy were excluded from both groups of this study.
The US participants are comprised of 94 adult patients (48 HCC cases and 46 patients with liver cirrhosis), recruited from the hepatology clinics at MedStar Georgetown University Hospital, Washington, DC (GU cohort). The characteristics of the GU cohort are summarized in Table S2 . All patients provided informed consent and the study was approved by the Institutional Review Board at Georgetown University. All patients were diagnosed to have liver cirrhosis on the basis of established clinical, laboratory and/or imaging criteria. Cases were diagnosed to have HCC based on well-established diagnostic imaging criteria and/or histology. Clinical stages for HCC cases are determined based on the TNM staging system. Controls were required to be HCC free for at least 6 months from the time of study entry.
Ethics Approvals
TU Cohort-We analyzed de-identified and anonymous samples from study participants previously recruited at Tanta University Hospital following approval by their ethical committee. After sample collection, coded/de-identified samples were transported in dried ice to Georgetown University and stored in -80°C freezer until use. Along with the samples, we received a data set of non-identifiable information including age, gender, viral infection status, and disease stage of the study participants. We did not have access to identifying information or any information that allow to readily ascertaining the identity of the participants in the TU cohort.
GU Cohort-We analyzed de-identified and anonymous samples from study participants previously recruited at MedStar Georgetown University Hospital following approval by the Georgetown University Institutional Review Board committee. After collection in Georgetown University Hospital, coded/deidentified samples were stored in -80 °C freezer until use. Along with the samples, we received a data set of non-identifiable information including age, gender, viral infection status, and disease stage of the study participants. We did not have access to identifying information or any information that allow to readily ascertaining the identity of the participants in the GU cohort. Table S3 shows the acquisition order of LC-ESI-MS data and LC-ESI-MRM-MS data. Samples of HCC cases and cirrhotic controls were analyzed following the randomized order. Four batches in each cohort were analyzed continuously.
LC-ESI-MS Data Acquisition Order

Curation of MRM Transitions
Targeted quantitation of 117 N-glycans including isomers was performed by MRM using a QqQ mass spectrometer. The 117 N-glycans were represented by 213 channels (three transitions in each) consisting of their different adduct forms and charge states as shown in Table S4 . The transitions in each channel were determined based on expected fragments of the targeted glycan structure. Manual curation was performed to select channels with concurrent signals from three transitions in majority of the LC-ESI-MRM-MS runs. Channels with unfavorable chromatographic profiles or significant noises were eliminated from the subsequent analysis. Owing to the unit resolution in Q1 and Q3, interferences may appear across channels with close m/z values in their transitions. Ambiguous cases of interfering channels were further elucidated based on 1) relative intensities between channels, 2) represented adduct forms with preference on protonated ions, 3) confirmation from concurrent signals of associated adduct forms, and 4) elution order observed on the Orbitrap system. In consideration of these factors, we selected 65 channels representing 82 potential isomeric peaks of 52 N-glycans for the quantitation (Table S6 ). An appropriate window (width of 180 s) capturing RT variation was determined for each isomeric peak in each batch. The largest value of total ion counts forming a peak (width of 75 s) was searched within the window for each MRM run. Overlapping chromatographic traces were observed and indistinguishable in some channels. In those cases, a wider peak width (150 s) was used for quantitation. 
